Simplify Logo

Full-Time

Head of Regulatory Operations

Posted on 7/26/2024

Alltrna

Alltrna

51-200 employees

Develops tRNA-based therapies for diseases

Data & Analytics
Hardware
AI & Machine Learning
Biotechnology
Healthcare

Expert

Cambridge, MA, USA

Category
Risk & Compliance
Legal & Compliance
Required Skills
Communications
Requirements
  • BA/BS degree in a scientific/engineering discipline
  • Advanced degree a plus
  • Strong understanding of global regulatory requirements and guidelines (FDA, EMA, ICH, etc.) for drug development and submissions
  • Experience with electronic document management systems and regulatory submission software (e.g., Veeva Vault, docuBridge)
  • Minimum of 10 years of regulatory experience in the biopharmaceutical industry
  • Demonstrated leadership and success in management of regulatory activities with a proven track record of effective collaboration with regulatory agencies
  • Regulatory knowledge across therapeutic areas including rare diseases is preferable
  • Ability to collaborate effectively in a dynamic, cross-functional matrix environment to drive meeting each program’s critical regulatory milestones
  • Prior experience with FDA and EMA, and success with filing BLAs/NDAs/MAAs. Experience with both early and late-stage drug development
  • Experience required with preparing regulatory documents including new INDs/CTAs, Investigator Brochures, DSURs, briefing packages, PIPs and other documents for regulatory submissions worldwide
  • Strategic thinker who can balance near term objectives with long term goals and outcomes
  • Strong verbal and written communication skills; ability to clearly articulate regulatory viewpoints to a diverse audience
  • Ability to thrive in a collaborative and fast-paced team environment
  • Recognized internally and externally as an expert in gene therapy and other biologics regulations, guidelines and precedents related to pharmaceutical development
Responsibilities
  • Providing leadership and contributing with hands-on support as needed in managing, planning, coordinating, and preparing all documents submitted to FDA/EMA and other Health Authorities
  • Serving as overall regulatory operations lead accountable for all regulatory aspects of assigned projects
  • Works collaboratively with contributing cross-functional team members in order to create and maintain regulatory submission project plans
  • Ensuring that the regulatory strategy for assigned projects is consistent with the business objectives and have been negotiated with relevant health authorities as appropriate
  • Oversees the planning of all regulatory submissions in electronic format
  • Accountable for the oversight of regulatory submission processes and best practices
  • Provides key insight to identify IT solutions to enhance Regulatory Operations systems
  • Participates in the writing of regulatory processes and other departmental initiatives to improve standards and systems

Alltrna focuses on developing tRNA therapeutics to treat diseases caused by genetic mutations. Their main product involves engineered tRNAs that can recognize and read stop codons, which are errors in the genetic code that lead to the production of incomplete proteins. By delivering the correct amino acids, these tRNAs help restore the production of full-length proteins, potentially addressing a wide range of diseases linked to nonsense mutations. Unlike other biotech companies, Alltrna is the first to explore the therapeutic potential of tRNA in this way, aiming to unlock new treatment options for patients with specific genetic disorders. The goal of Alltrna is to provide effective treatments that target the root causes of diseases, improving the quality of life for those affected.

Company Stage

Series B

Total Funding

$159M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

-11%

1 year growth

-5%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $109 million Series B financing round provides substantial capital to advance their platform and drug candidates, indicating strong investor confidence.
  • Presentations at high-profile conferences like ASGCT and TIDES USA 2024 highlight Alltrna's growing recognition and thought leadership in the biotech community.
  • The appointment of experienced leaders like Chris Henderson as Chief Scientific Officer strengthens their executive team, potentially accelerating innovation and clinical progress.

What critics are saying

  • The novel nature of tRNA therapeutics means there is a high level of scientific and clinical uncertainty, which could delay or derail development efforts.
  • The competitive biotech landscape, especially in genetic therapies, requires continuous innovation to maintain a leading position.

What makes Alltrna unique

  • Alltrna is the first biotech company to decode tRNA biology and leverage it for therapeutic purposes, setting it apart in the biotech landscape.
  • Their focus on treating diseases caused by nonsense mutations through tRNA therapeutics is a unique approach that addresses a significant unmet medical need.
  • The integration of AI/ML tools in their platform enhances their capability to develop diverse programmable molecules, providing a technological edge over competitors.
INACTIVE